Explore the vast range of titles available.

Presents information about the people, geography, culture, history, government, and economy of Mexico.

Each person should be able to control his own body by deciding if and when he will take medication. No one should be forced by the government to ingest a drug each time he takes a drink of water or uses water in his cooking.

Vaccination against 5 prominent meningococcal serogroups (A/B/C/W/Y) is necessary for broad disease protection. We report immunopersistence through 4 years after a 2-dose (6-month interval) pentavalent MenABCWY primary vaccine series and safety and immunogenicity of a booster administered 4 years after primary vaccination. This randomized, active-controlled, observer-blinded study was conducted in the United States and Europe. In stage 1, healthy MenACWY vaccine-naive or -experienced 10- to 25-year-olds were randomized 1:2 to receive MenABCWY and placebo or MenB-fHbp and MenACWY-CRM. Eligible participants were randomly selected to participate in stage 2, which was an open-label immunopersistence and booster extension. Immunogenicity was assessed through serum bactericidal antibody using human complement (hSBA) assays with serogroups A/C/W/Y (MenA/C/W/Y) and 4 primary serogroup B (MenB) test strains. Immunogenicity endpoints included hSBA seroprotection rates through 48 months after primary vaccination and 1 month after the booster. Safety endpoints included booster reactogenicity events and adverse events (AEs). Of 1379 eligible participants, 353 entered stage 2; 242 completed the 48-month blood draw after primary vaccination and 240 completed the booster vaccination phase. MenA/C/W/Y seroprotection rates remained high for 4 years following a 2-dose MenABCWY primary series (MenACWY-naive, 62.0 %–100.0 %; MenACWY-experienced, 98.7 %–100.0 %) and trended higher than those after a single MenACWY-CRM dose (MenACWY-naive, 38.1 %–95.2 %; MenACWY-experienced, 89.7 %–100.0 %). Corresponding seroprotection rates against MenB remained stable and generally higher than baseline (MenABCWY, 18.2 %–36.6 %; MenB-fHbp, 16.2 %–31.9 % across strains). Following a booster, seroprotection rates against all 5 serogroups were ≥ 93.8 % across groups. Most booster dose reactogenicity events were mild or moderate in severity, and AEs were infrequent. Immune responses remained high for MenA/C/W/Y and above baseline for MenB through 4 years after the MenABCWY primary series, with robust responses for all 5 serogroups observed following a booster. The MenABCWY booster had an acceptable safety and tolerability profile consistent with the primary series. NCT03135834. •Broad protection against meningococcal disease requires serogroup ABCWY vaccination•Immunopersistence up to 4y post MenABCWY primary and booster responses are reported•Seroprotection stayed high (ACWY) and largely >baseline (B) for 4y postvaccination•A MenABCWY booster at 4y induced anamnestic immune responses for all 5 serogroups•The booster had acceptable safety and tolerability, similar to the primary series

Background: Particulated juvenile articular cartilage (PJAC) implantation has demonstrated promising early results in the treatment of symptomatic articular cartilage defects of the patella. However, some uncertainty exists regarding the stability of this cell-based technique in lesions that are not well contained or shouldered. Purpose: To compare clinical and magnetic resonance imaging (MRI) outcomes of PJAC treatment in shouldered versus unshouldered full-thickness cartilage defects of the patella. Study Design: Cohort study; Level of evidence, 3. Methods: A retrospective review of prospectively collected data from an institutional knee registry was conducted to identify patients treated with PJAC for full-thickness symptomatic patellar cartilage lesion between January 2009 and August 2017. Cartilage defects were graded arthroscopically according to the Outerbridge classification and characterized as shouldered or unshouldered. For the primary outcome, postoperative MRI studies were read by a musculoskeletal fellowship-trained radiologist who characterized the percentage of fill based on both coronal and sagittal images. Patient-reported outcome measures (PROMs) were obtained at baseline and 2-year follow-up. MRI and PROM results were compared between the shouldered and unshouldered cohorts. Results: A total of 64 knees in 60 patients (mean age, 26.3 ± 7.6 years) were identified, of which 62 (97%) knees underwent a concomitant patellar stabilization or offloading procedure. There were 32 (50%) shouldered and 32 (50%) unshouldered defects. On postoperative MRI, 68.8% of shouldered lesions demonstrated 67% to 100% fill, compared with 59.4% of unshouldered lesions; 12.5% of shouldered lesions and 15.6% of unshouldered lesions demonstrated 34% to 66% fill; and 18.8% of shouldered lesions and 25.0% of unshouldered lesions demonstrated 0% to 33% fill (P = .604). At 2 years, significant improvements were observed in Knee Injury and Osteoarthritis Outcome Score (KOOS) Quality of Life (QOL) (23.1 to 65.3; P < .001), International Knee Documentation Committee (IKDC) (41.2 to 76.0; P < .001), KOOS Physical Function Shortform (PS) (34.8 to 13.9; P < .001), Kujala (52.0 to 87.5; P < .001), 12-Item Short Form Survey (SF-12) Physical Health (39.5 to 51.5; P < .001), Veterans Rand 12 Item Health Survey (VR-12) Physical Health (40.7 to 52.8; P < .001), Veterans Rand 6D (0.66 to 0.79; P < .001), SF-12 Mental Health (48.9 to 53.4; P = .015), and VR-12 Mental Health (49.4 to 54.0; P = .019) values. No significant change was observed in Pediatric Functional Activity Brief Scale score (9.1 to 10.3; P = .384). All PROMs were equivalent between shouldered and unshouldered defects at the 2-year follow-up (P = .318-.980). There was a greater improvement in both KOOS PS (27.2 vs 10.7; P = .015) and Kujala (44.3 vs 26.9; P = .039) values from baseline to the 2-year follow-up in the shouldered group. Conclusion: PJAC implantation with concomitant patellar stabilization led to significantly improved PROMs for both shouldered and unshouldered patellar cartilage lesions over time. Additionally, minimal differences were observed between shouldered and unshouldered defects treated with PJAC at the 2-year follow-up.

Background: Cartilage restoration procedures for patellar cartilage defects have produced inconsistent results, and optimal management remains controversial. Particulated juvenile articular cartilage (PJAC) allograft tissue is an increasingly utilized treatment option for chondral defects, with previous studies demonstrating favorable short-term outcomes for patellar chondral defects. Purpose: To identify whether there is an association between defect fill on magnetic resonance imaging (MRI) with functional outcomes in patients with full-thickness patellar cartilage lesions treated with PJAC. Study Design: Case series; Level of evidence, 4. Methods: A retrospective review of prospectively collected data was conducted on patients treated with PJAC for a full-thickness symptomatic patellar cartilage lesion between March 2014 and August 2019. MRI was performed for all patients at 6, 12, and 24 months postoperatively. Patient-reported outcome measures (PROMs) were obtained preoperatively and at 1, 2, and >2 years postoperatively. Clinical outcome scores—including the International Knee Documentation Committee (IKDC) score, the Kujala, the Knee injury and Osteoarthritis Outcome Score–Physical Function Short Form (KOOS-PS), the Knee Injury and Osteoarthritis Outcome Score–Quality of Life (KOOS-QoL), and the Hospital for Special Surgery Pediatric Functional Activity Brief Scale (HSS Pedi-FABS)—were analyzed and evaluated for a relationship with tissue fill on MRI. Results: A total of 70 knees in 65 patients (mean age, 26.6 ± 8.1 years) were identified, of which 68 knees (97%) underwent a concomitant patellar stabilization or offloading procedure. Significant improvements were observed on all postoperative PROM scores at the 1-, 2-, and >2-year follow-up except for the Pedi-FABS, which showed no significant difference from baseline. From baseline to the 2-year follow-up, the KOOS-QoL improved from 24.7 to 62.1, the IKDC improved from 41.1 to 73.5, the KOOS-PS improved from 35.6 to 15, and the Kujala improved from 52 to 86.3. Imaging demonstrated no difference in the rate of cartilage defect fill between the 3-month (66%), 6-month (72%), 1-year (74%), and ≥2-year (69%) follow-ups. No association was observed between PROM scores and the percent fill of cartilage defect on MRI at the 1- and 2-year follow-up. Conclusion: PROM scores were significantly improved at the 2-year follow-up in patients who underwent PJAC for full-thickness patellar cartilage defects. On MRI, a cartilage defect fill of >66% was achieved by 3 months in most patients. In our sample, PROM scores were not significantly associated with the defect fill percentage at the short-term follow-up.

من ضفاف نهر دجلة إلى مدينة أور السومرية بحث علماء الآثار فى العراق لسنين طويلة عن أدلة لتاريخ شعب العراق اقرأ عن المئذنة الحلزونية فى سامراء انظر إلى الطرز المعمارية الرائعة والتقويم المكتوب بالخط المسمارى التي ابتكرها الفنانون الأشوريون فى كاليخو \"نيمرود\" تعرف كيف ساعدت الكنوز القديمة علماء الآثار اليوم فى جمع تاريخ ماضي العراق كل قطعة فنية اكتشفت قدمت إلينا فهما جديدا للعراق القديم أنها مهمة ناشيونال جيوجرافيك لاستكشاف العالم وكل ما فيه لتقديم آخر الاكتشافات وأحدث المعلومات إلى أكبر عدد من الشباب فى جميع أنحاء العالم فهذه السلسلة تقدم لقرائها الشباب أحدث أساليب البحث والتنقيب والاكتشافات الحالية والطريقة التي بها تلقي تلك الاكتشافات مزيدا من الضوء على واحدة من أعرق حضارات العالم.

Objectives: Unique challenges exist in treating patellar cartilage defects such as the contour of the articular surface and the high dynamic shear and compressive forces at the trochlear articulation. When considering restoration techniques osteochondral autograft or allograft can be used when the underlying bone is also involved but for isolated chondral defects, cell-based restoration is the standard of care. Previous literature has demonstrated that success of these cell-based therapies depends on a fully shouldered, stable rim of healthy cartilage to achieve repair stability. More recently, particulated juvenile articular cartilage (PJAC), minced hyaline cartilage from young donors, has demonstrated promising and practical results in the treatment of symptomatic articular defects of the patella and other surfaces. The newer cell-based techniques are more stable than previous options such as autologous chondrocyte implantation (ACI). The purpose of this study is to compare clinical outcomes of PJAC in patients with shouldered versus unshouldered full-thickness cartilage defects of the patella. We hypothesized that there will be no significant difference in short-term clinical outcomes and radiographic cartilage fill between shouldered and unshouldered lesions. Methods: A retrospective review of prospectively collected data was conducted on patients treated with PJAC for a full-thickness symptomatic patellar cartilage lesion between March 2014 and August 2019. Magnetic resonance imaging (MRI) was performed for all patients at 6, 12, and 24 months postoperatively and analyzed for percent fill, categorized by 0% to 33%, 34% to 66%, and 67% to 100% fill. Patient-reported outcome measures (PROMs) were obtained preoperatively and at 1, 2 and >2 years postoperatively. Arthroscopic images were independently assessed, and cartilage defect characteristics were documented as shouldered or unshouldered by an orthopaedic surgery resident and an orthopaedic surgery sports fellow. Percent fill on MRI and clinical outcome scores (International Knee Documentation Committee, Kujala, Knee injury and Osteoarthritis Outcome Score – Physical Function Short-Form [KOOS-PS], Knee injury and Osteoarthritis Outcome Score – Quality of Life, The Hospital for Special Surgery Pediatric Functional Activity Brief Scale) were analyzed and correlated with the shouldered or unshouldered classification of the lesions. Results: Between March 2014 and August 2019, a total of 70 lesions in 65 patients were treated with PJAC for patellar cartilage lesions. The mean patient age was 26.6 years old (range, 14 – 51) and 76% (n = 53) were female. Twenty-five (36%) knees had undergone prior surgery and average symptom duration was 7.5 years. The average patellar lesion size was 277 mm2 (range, 77 – 800 mm2), the average number of allografts packets used was 2.4 (range, 1 – 5), and the average donor age was 46.1 months (range, 1 – 120). Arthroscopic pictures were available for 64 out of 70 lesions. There was perfect inter-rater reliability of whether the lesions were considered to have a continuous, stable rim (shouldered) or not (unshouldered). Thirty-two lesions were shouldered and the remaining 32 lesions were unshouldered according to their intraoperative pictures. Patients with shouldered lesions reported a significantly lower duration of symptoms than those with unshouldered lesions (5.29 ± 7.12 years vs.10.11 ± 9.85 years, p < 0.05). Patients with shouldered lesions were also significantly more likely to have a prior knee surgery (p < 0.05). Patients did not differ significantly by MRI percent fill in the shouldered versus unshouldered groups (Figure 1). There were no significant differences in baseline, 1-, or 2-year patient-reported outcomes based between patients with shouldered and unshouldered lesions (Table 1). The only statistically significant difference in outcomes was a lower score for KOOS-PS in the unshouldered group at >2 years compared to the shouldered group (p < 0.05), and in the change in KOOS-PS from baseline to 2-years between the 2 groups (p <0.05). Conclusions: Patellofemoral joint cartilage defects are difficult to treat due to their unique thickness and topography. Historically, emphasis has been placed on having a stable, fully shouldered defect in order to achieve success of repair with microfracture or ACI. However, with the increased stability of newer cell-based treatments, these unshouldered cartilage lesions do well both clinically and radiographically. Our study found no significant differences between the shouldered and unshouldered groups with regard to both clinical outcomes as well as radiographic cartilage fill. This suggests that, with newer cartilage restoration techniques, whether a lesion is shouldered does not affect the outcomes achieved by these procedures. Figure 1